Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 43 citing articles:

Inorganic–inorganic nanohybrids for drug delivery, imaging and photo-therapy: recent developments and future scope
Goeun Choi, N. Sanoj Rejinold, Huiyan Piao, et al.
Chemical Science (2021) Vol. 12, Iss. 14, pp. 5044-5063
Open Access | Times Cited: 73
New insights into the potential of exosomal circular RNAs in mediating cancer chemotherapy resistance and their clinical applications
Qiang Li, Yuhao Zhang, Peikan Jin, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117027-117027
Open Access | Times Cited: 5
Circular RNAs as Key Regulators in Cancer Hallmarks: New Progress and Therapeutic Opportunities
Bashdar Mahmud Hussen, Snur Rasool Abdullah, Rohana Jaafar, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104612-104612
Open Access
Frequent Dysregulation of Multiple Circular RNA Isoforms with Diverse Regulatory Mechanisms in Cancer — Insights from CircFNDC3B and Beyond: Why Unique Circular RNA Identifiers Matter
Chiu-Jung Huang, Kong‐Bung Choo
Biochemical and Biophysical Research Communications (2025), pp. 151627-151627
Closed Access
Cadmium promotes apoptosis and inflammation via the circ08409/miR-133a/TGFB2 axis in bovine mammary epithelial cells and mouse mammary gland
Zhi Chen, Yan Liang, QinYue Lu, et al.
Ecotoxicology and Environmental Safety (2021) Vol. 222, pp. 112477-112477
Open Access | Times Cited: 33
The Role of Circular RNAs in the Drug Resistance of Cancers
Xinyuan Liu, Qi Zhang, Jing Guo, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 23
MicroRNA-377: A therapeutic and diagnostic tumor marker
Iman Akhlaghipour, Negin Taghehchian, Amir Sadra Zangouei, et al.
International Journal of Biological Macromolecules (2022) Vol. 226, pp. 1226-1235
Closed Access | Times Cited: 23
The role of noncoding RNAs in metabolic reprogramming of cancer cells
Amir Safi, Mohammadreza Saberiyan, Mohammad‐Javad Sanaei, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 13
Knock-down of microRNA miR-556-5p increases cisplatin-sensitivity in non-small cell lung cancer (NSCLC) via activating NLR family pyrin domain containing 3 (NLRP3)-mediated pyroptotic cell death
Feng Shi, Luquan Zhang, Xing Liu, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 6332-6342
Open Access | Times Cited: 28
MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin
Maria Konoshenko, Yuriy Lansukhay, Sergey E. Krasilnikov, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7594-7594
Open Access | Times Cited: 18
CircPTK2 inhibits cell cisplatin (CDDP) resistance by targeting miR-942/TRIM16 axis in non-small cell lung cancer (NSCLC)
Yongfu Wang, Yuanlin Wu, Shaoqiang Xie
Bioengineered (2022) Vol. 13, Iss. 2, pp. 3651-3664
Open Access | Times Cited: 15
Macrophage-derived exosomes regulate gastric cancer cell oxaliplatin resistance by wrapping circ 0008253
Dandan Yu, Zhiwei Chang, Xiaolei Liu, et al.
Cell Cycle (2022) Vol. 22, Iss. 6, pp. 705-717
Open Access | Times Cited: 14
The diagnostic potential of a circRNA–miRNA network in non-small cell lung cancer
Xinyi Ma, Chengtao Lou, Junjie Pan, et al.
Journal of Molecular Medicine (2023) Vol. 101, Iss. 6, pp. 671-684
Closed Access | Times Cited: 8
Circ_0010235 confers cisplatin resistance in lung cancer by upregulating E2F7 through absorbing miR‐379‐5p
Lifei Wang, Dongchang Wang, Zhen Xu, et al.
Thoracic Cancer (2023) Vol. 14, Iss. 20, pp. 1946-1957
Open Access | Times Cited: 8
Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review
Pía Loren, Nicolás Saavedra, Kathleen Saavedra, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 12
Emerging noncoding RNAs contained in extracellular vesicles: rising stars as biomarkers in lung cancer liquid biopsy
Giuseppe Cammarata, Diego Pérez, Alessandro Russo, et al.
Therapeutic Advances in Medical Oncology (2022) Vol. 14, pp. 175883592211312-175883592211312
Open Access | Times Cited: 12
Circ‐SNAP47 (hsa_circ_0016760) and miR‐625‐5p are regulators of WEE1 in regulation of chemoresistance, growth and invasion of DDP‐tolerant NSCLC cells via ceRNA pathway
Can Zou, Rong Feng, Yan Zeng, et al.
Environmental Toxicology (2021) Vol. 37, Iss. 2, pp. 224-236
Closed Access | Times Cited: 15
Advances in the Study of CircRNAs in Tumor Drug Resistance
Song Wang, Long Qian, Tingting Cao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 10
Hsa_circ_0041150 serves as a novel biomarker for monitoring chemotherapy resistance in small cell lung cancer patients treated with a first-line chemotherapy regimen
Y Zhang, Fengmei Chao, Lihua Lv, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 17, pp. 15365-15382
Open Access | Times Cited: 5
Circ-CUL2/microRNA-888-5p/RB1CC1 axis participates in cisplatin resistance in NSCLC via repressing cell advancement
Hengchi Chen, Li Fang, Qi Xue
Bioengineered (2022) Vol. 13, Iss. 2, pp. 2826-2838
Open Access | Times Cited: 9
Circular RNAs in lung cancer: implications for preventing therapeutic resistance
Wenjuan Liu, Yawen Sun, Yanfei Huo, et al.
EBioMedicine (2024) Vol. 107, pp. 105309-105309
Open Access | Times Cited: 1
Emerging role of circular RNAs in the pathobiology of lung cancer
Soudeh Ghafouri‐Fard, Marcel E. Dinger, Parichehr Maleki, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111805-111805
Open Access | Times Cited: 12
Biogenesis, Functions, and Role of CircRNAs in Lung Cancer
Huanhuan Dong, Junliang Zhou, Yue Cheng, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 6651-6671
Open Access | Times Cited: 12
Cisplatin resistance and malignant behaviors of lung cancer cells are promoted by circ_0002360 via targeting miR‐6751‐3p to regulate the expression of ZNF300
Lingyan Ding, Lizhi Li, Zhaohui Tang
Thoracic Cancer (2022) Vol. 13, Iss. 7, pp. 986-996
Open Access | Times Cited: 8
Fabrication and evaluation of a dual-targeting nanoparticle mediated CRISPR/Cas9 delivery to combat drug resistance in breast cancer cells
Nazita Tavazohi, Mina Mirian, Jaleh Varshosaz, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 86, pp. 104628-104628
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top